July 29 (Reuters) - Swiss pharmaceutical company Roche

plans to fast-track its anti-obesity drugs to challenge

Eli Lilly ( LLY ) and Novo Nordisk after unveiling

promising data for a weight-loss pill, the Financial Times

reported on Monday.

Thomas Schinecker, CEO of Roche told the newspaper that

their first obesity drugs would come to market "significantly

faster than people are expecting", potentially by 2028.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Varun H K)